(Q54084914)

24 May 2018

title

Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. (English)

1 reference

24 May 2018

1 reference

M A Rogy

1

1 reference

24 May 2018

L L Moldawer

2

1 reference

24 May 2018

H S Oldenburg

3

1 reference

24 May 2018

W A Thompson

4

1 reference

24 May 2018

W J Montegut

5

1 reference

24 May 2018

S A Stackpole

6

1 reference

24 May 2018

A Kumar

7

1 reference

24 May 2018

M A Palladino

8

1 reference

24 May 2018

M N Marra

9

1 reference

24 May 2018

S F Lowry

10

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 July 1994

1 reference

24 May 2018

published in

Annals of Surgery

1 reference

24 May 2018

volume

220

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

77-85

1 reference

24 May 2018

The effects of bacterial endotoxins on host mediation systems. A review

cites work

1 reference

12 December 2020

The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock.

1 reference

12 December 2020

Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis

1 reference

12 December 2020

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity

1 reference

12 December 2020

Mediators of Inflammation

1 reference

12 December 2020

Characterization of murine monoclonal antibodies to Escherichia coli J5

1 reference

12 December 2020

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

12 December 2020

Endotoxins and disease mechanisms

1 reference

12 December 2020

Production of hybridoma growth factor by human monocytes.

1 reference

12 December 2020

Quantitative measurement of endotoxin in canine plasma using the new endotoxin-specific chromogenic test

1 reference

12 December 2020

Cytokine appearance in human endotoxemia and primate bacteremia

1 reference

12 December 2020

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

12 December 2020

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

12 December 2020

Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man

1 reference

12 December 2020

Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein.

1 reference

12 December 2020

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

12 December 2020

Monoclonal antibodies for treatment of gram-negative infections

1 reference

12 December 2020

Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity

1 reference

12 December 2020

Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha

1 reference

12 December 2020

Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli

1 reference

12 December 2020

Structure and function of lipopolysaccharide binding protein

1 reference

12 December 2020

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

12 December 2020

Induction of plasma inhibitors of interleukin 1 and TNF-alpha activity by endotoxin administration to normal humans

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14

1 reference

12 December 2020

Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.

1 reference

12 December 2020

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis

1 reference

12 December 2020

The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin

1 reference

12 December 2020

Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal

1 reference

12 December 2020

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

12 December 2020

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

12 December 2020

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria

1 reference

12 December 2020

Lipopolysaccharide antagonists

1 reference

12 December 2020

Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein

1 reference

12 December 2020

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide

1 reference

12 December 2020

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

12 December 2020

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14

1 reference

12 December 2020

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

1 reference

12 December 2020

Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade

1 reference

12 December 2020

Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide

1 reference

12 December 2020

Introduction of new technology into critical care practice: a history of HA-1A human monoclonal antibody against endotoxin.

1 reference

12 December 2020

Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.

1 reference

12 December 2020

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

1 reference

12 December 2020

Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients

1 reference

12 December 2020

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

12 December 2020

10.1097/00000658-199407000-00011

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018